Go Pro

32,488 Shares in The Clorox Company $CLX Acquired by Canada Pension Plan Investment Board

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • Canada Pension Plan Investment Board acquired 32,488 Clorox shares worth approximately $3.1 million in the second quarter. Institutional investors collectively own 78.53% of CLX.
  • Analyst sentiment remains cautious, with a consensus “Reduce” rating and an average price target of $102.40. Twelve analysts rate the stock Hold and five rate it Sell.
  • Clorox exceeded quarterly earnings and revenue estimates, reporting $1.66 EPS and $1.95 billion in revenue, though sales fell 2% year over year. The company raised its quarterly dividend to $1.25, implying a 4.9% yield.
  • Interested in Clorox? Here are five stocks we like better.

Canada Pension Plan Investment Board purchased a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 32,488 shares of the company's stock, valued at approximately $3,101,000.

Other large investors also recently modified their holdings of the company. Caitlin John LLC lifted its position in shares of Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company's stock worth $27,000 after purchasing an additional 253 shares during the last quarter. Avalon Trust Co acquired a new stake in Clorox in the second quarter valued at $29,000. Darwin Wealth Management LLC acquired a new stake in Clorox in the second quarter valued at $29,000. Root Financial Partners LLC lifted its holdings in Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company's stock worth $33,000 after buying an additional 145 shares during the last quarter. Finally, SHP Wealth Management purchased a new stake in Clorox during the 4th quarter worth about $35,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CLX has been the topic of a number of recent analyst reports. Wall Street Zen downgraded Clorox from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. BNP Paribas Exane decreased their target price on Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft set a $98.00 price target on Clorox in a report on Tuesday, August 4th. Wells Fargo & Company increased their price target on shares of Clorox from $95.00 to $102.00 and gave the company an "equal weight" rating in a research note on Tuesday, August 4th. Finally, Jefferies Financial Group cut shares of Clorox from a "buy" rating to a "hold" rating and cut their price objective for the stock from $125.00 to $98.00 in a report on Tuesday, July 28th. Twelve equities research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company's stock. According to data from MarketBeat, Clorox has a consensus rating of "Reduce" and an average target price of $102.40.

Read Our Latest Research Report on CLX

Clorox Stock Up 0.0%

CLX opened at $102.57 on Monday. The Clorox Company has a one year low of $84.70 and a one year high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The stock has a market capitalization of $12.40 billion, a P/E ratio of 21.28, a price-to-earnings-growth ratio of 3.21 and a beta of 0.54. The business's 50-day simple moving average is $99.83 and its 200-day simple moving average is $102.60.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion during the quarter, compared to analysts' expectations of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business's revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Analysts anticipate that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were issued a $1.25 dividend. The ex-dividend date of this dividend was Wednesday, August 12th. This is an increase from Clorox's previous quarterly dividend of $1.24. This represents a $5.00 annualized dividend and a dividend yield of 4.9%. Clorox's dividend payout ratio is currently 103.73%.

Clorox Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own - Summer 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines